Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03979040 · ClinicalTrials.gov registry record · NA

Comparing Group Therapies for Veterans With Depression and PTSD

A NA study of Major Depressive Disorder and Posttraumatic Stress Disorder, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
294
Enrollment target
1
Study location

NCT03979040 is a NA study of Major Depressive Disorder and Posttraumatic Stress Disorder that has completed, run by VA Office of Research and Development. The registered enrollment target is 294 participants, below the 376-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (22% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03979040, a NA study of Major Depressive Disorder and Posttraumatic Stress Disorder, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
294 participants
Enrollment target
1
Study location

Study Summary

Cognitive behavioral therapy (CBT) is a brief, efficient, and effective psychotherapy for individuals with depressive and PTSD. However, CBT is largely underutilized within Veteran Affairs Medical Centers (VAMCs) due to the cost and burden of trainings necessary to deliver the large number of CBT protocols. Transdiagnostic Behavior Therapy (TBT), in contrast, is specifically designed to address numerous distinct disorders within a single protocol. The transdiagnostic approach of TBT has the potential to dramatically improve the accessibility of CBT within VAMCs and therefore improve clinical outcomes of Veterans. The proposed research seeks to evaluate the efficacy of a group version of TBT (G-TBT) by assessing clinical outcomes and quality of life in VAMC patients with major depressive disorder and PTSD throughout the course of treatment and in comparison to two existing group disorder-specific therapies (G-DST), CBT for Depression and Cognitive Processing Therapy for PTSD.

Interventions

  • BEHAVIORAL Group Transdiagnostic Behavior Therapy
  • BEHAVIORAL Group Disorder-Specific Therapy (G-DSTs)

Study Locations (1)

South Carolina

  • Ralph H. Johnson VA Medical Center, Charleston, SC - Charleston

Trial Details

FieldValue
Enrollment Target 294 participants
Start Date 2021-02-03
Est. Completion 2024-03-30
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT03979040

The ClinicalTrials.gov registry entry for NCT03979040 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 294 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 376-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (22% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Major Depressive Disorder appearing as the primary indexed condition, and to 2 interventions - of which Group Transdiagnostic Behavior Therapy is the first listed.

NCT03979040 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.

Frequently Asked Questions

What is clinical trial NCT03979040 about?

NCT03979040 is a clinical study titled "Comparing Group Therapies for Veterans With Depression and PTSD". Cognitive behavioral therapy (CBT) is a brief, efficient, and effective psychotherapy for individuals with depressive and PTSD. However, CBT is largely underutilized within Veteran Affairs Medical Centers (VAMCs) due to the cost and burden of trainings necessary to deliver the large number of CBT pr...

What is the current status of trial NCT03979040?

This trial is currently completed. It is a NA study. The enrollment target is 294 participants. The study started on 2021-02-03. Estimated completion is 2024-03-30.

What conditions does trial NCT03979040 study?

This clinical trial studies the following conditions: Major Depressive Disorder, Posttraumatic Stress Disorder.

What interventions are being tested in trial NCT03979040?

The interventions under investigation include: Group Transdiagnostic Behavior Therapy (BEHAVIORAL), Group Disorder-Specific Therapy (G-DSTs) (BEHAVIORAL).

Who is sponsoring clinical trial NCT03979040?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03979040 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Major Depressive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.